2021, Maeda H, Okabe A, Sakakura K, Ng DB, Akazawa M. Relationships between developmental strategies for additional indications and price revisions for anticancer drugs in Japan. BMC Health Serv Res. 2021 Dec 11;21(1):1329. doi: 10.1186/s12913-021-07360-w.